ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.

August 8, 2003

Ontak Approved For Lymphoma

October 31, 2008

New NCI Grant Program Will Support Young Scientists In Innovative, “Risky” Research

May 27, 1977